---
figid: PMC8196612__ijms-22-05431-g003
figtitle: Neuroprotective and Immunomodulatory Action of the Endocannabinoid System
  under Neuroinflammation
organisms:
- Mus musculus
- Rattus norvegicus
- Escherichia coli
- Staphylococcus aureus
- Homo sapiens
- Canis lupus familiaris
- Human alphaherpesvirus 1
- Turdus migratorius
- Canna indica
organisms_ner:
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
- Rattus norvegicus
pmcid: PMC8196612
filename: ijms-22-05431-g003.jpg
figlink: /pmc/articles/PMC8196612/figure/ijms-22-05431-f003/
number: F3
caption: Signaling pathway and anti-inflammatory actions of NAEs. Arachidonoylethanolamide
  (AEA) signals via the cannabinoid receptors CB1/2, the non-cannabinoid G protein
  coupled receptor (GPR)55, the transient receptor potential cation channel subfamily
  V member 1 (TRPV1), and the peroxisome proliferator-activated receptor (PPAR)-α
  and γ. Palmitoylethanolamide (PEA) has been shown to inhibit the fatty acid amide
  hydrolase (FAAH) and to signal via GPR55, TRPV1, and PPAR-α, while CB1/2binding
  is still controversial. Oleoylethanolamide (OEA) activates TRPV1 and PPAR-α, while
  stearoylethanolamide (SEA) inhibits FAAH and activates PPAR-α. Linoleylethanolamide
  (LEA) was shown to activate TRPV1, GPR119, and to inhibit FAAH, while docosahexaenoylethanolamide
  (DHEA) signaling involves the activation of GPR110.
papertitle: Neuroprotective and Immunomodulatory Action of the Endocannabinoid System
  under Neuroinflammation.
reftext: Ludmila A. Kasatkina, et al. Int J Mol Sci. 2021 Jun;22(11):5431.
year: '2021'
doi: 10.3390/ijms22115431
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: endocannabinoids | N-acylethanolamines | neuroinflammation | glutamate-mediated
  excitotoxicity | neurodegenerative diseases | synaptic plasticity
automl_pathway: 0.8102917
figid_alias: PMC8196612__F3
figtype: Figure
redirect_from: /figures/PMC8196612__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8196612__ijms-22-05431-g003.html
  '@type': Dataset
  description: Signaling pathway and anti-inflammatory actions of NAEs. Arachidonoylethanolamide
    (AEA) signals via the cannabinoid receptors CB1/2, the non-cannabinoid G protein
    coupled receptor (GPR)55, the transient receptor potential cation channel subfamily
    V member 1 (TRPV1), and the peroxisome proliferator-activated receptor (PPAR)-α
    and γ. Palmitoylethanolamide (PEA) has been shown to inhibit the fatty acid amide
    hydrolase (FAAH) and to signal via GPR55, TRPV1, and PPAR-α, while CB1/2binding
    is still controversial. Oleoylethanolamide (OEA) activates TRPV1 and PPAR-α, while
    stearoylethanolamide (SEA) inhibits FAAH and activates PPAR-α. Linoleylethanolamide
    (LEA) was shown to activate TRPV1, GPR119, and to inhibit FAAH, while docosahexaenoylethanolamide
    (DHEA) signaling involves the activation of GPR110.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GPR55
  - CNR1
  - TRPV1
  - CNR2
  - FAAH
  - FA2H
  - SEA
  - MST1R
  - SLC25A1
  - GPR119
  - ADGRF1
  - Gpr55
  - Cnr1
  - Trpv1
  - Cnr2
  - Faah
  - Fa2h
  - sea
  - Seao
  - Gpr119
  - Adgrf1
---
